Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: Genmab Launches This Year's Biggest Biopharma IPO In The US

Jul 18 2019

• By Mandy Jackson

Finance Watch

Related Content

Keeping Track: First RMAT Approval On The Horizon; Big Weeks For Merck, Lilly And Celgene

Jun 07 2019

Finance Watch: Rough US Stock Market Doesn't Stop Biopharma IPOs As Six More Go Public

Oct 31 2018

Finance Watch: Polaris Piles On As Multiple Life Science VCs Raise New Funds

Jun 19 2019

Acer To Respond To Edsivo CRL In Ehlers-Danlos Syndrome

Jun 26 2019

Newly Hatched Mirum To Focus On Rare Liver Disease Candidates Shelved By Shire

Nov 07 2018

Finance Watch: Summer Heat Extends To Biopharma IPOs With Nine In July, 45 This Year

Aug 01 2018

BeyondSpring CEO On Plinabulin's Dual Regulatory Pathway For US and China

Aug 29 2018

Calliditas IPO To Support Phase III Berger's Disease Study

Jun 15 2018

Finance Watch: Is The IPO Boom Making Anyone Nervous Yet?

Jun 28 2018

Genmab Plots $500m Nasdaq IPO

May 30 2019

Related Companies

Genmab A/S

Fulcrum Therapeutics Inc.

Mirum Pharmaceuticals, Inc.

Annovis Bio, Inc.

RAPT Therapeutics, Inc.

Horizon Therapeutics plc

Horizon Therapeutics plc

AVROBIO, Inc.

Aquestive Therapeutics, Inc.

BeyondSpring Inc.

Sunesis Pharmaceuticals, Inc.

Calliditas Therapeutics AB

Leap Therapeutics, Inc.

LogicBio Therapeutics, Inc.

Abivax S.A.

Spero Therapeutics, Inc.

Inovio Pharmaceuticals, Inc.

Plus Therapeutics, Inc.

Acer Therapeutics Inc.

Additional Topics

Business Strategies Financing Innovation Commercial BioPharmaceutical

More from Strategy

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window